Dianthus Therapeutics (DNTH) Share-based Compensation Growth (1y) (2018 - 2025)
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Share-based Compensation Growth (1y) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 71.86% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -3.46% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -7.69% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -8.89% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -22.43% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -4.01% |
| 10 | Dianthus Therapeutics | 4.09 Bn | 3.69 Bn | - | 52.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 52.92% |
| Sep 30, 2025 | 41.14% |
| Jun 30, 2025 | 41.01% |
| Mar 31, 2025 | 91.38% |
| Dec 31, 2024 | 439.67% |
| Sep 30, 2024 | 153.92% |
| Jun 30, 2024 | -53.00% |
| Mar 31, 2024 | -57.17% |
| Dec 31, 2023 | 41.52% |
| Sep 30, 2023 | 167.08% |
| Jun 30, 2023 | 409.81% |
| Mar 31, 2023 | 279.61% |
| Dec 31, 2022 | -76.50% |
| Sep 30, 2022 | -82.53% |
| Jun 30, 2022 | -13.54% |
| Mar 31, 2022 | -13.09% |
| Dec 31, 2021 | -6.35% |
| Sep 30, 2021 | 60.57% |
| Jun 30, 2021 | -14.78% |
| Mar 31, 2021 | -20.00% |